Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT04235205 Org: User:
Start: 01/29/20 End: 09/30/21 Due: 09/30/22

Shared Decision Making for Patients With First-admission Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01869660 Org: User:
Start: 06/30/13 End: 10/31/15 Due: 10/31/16

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00336947 Org: User:
Start: 04/30/06 End: - Due: -

Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial

Phase: N/A Priority: Normal
NCT ID: NCT04118699 Org: User:
Start: 12/25/19 End: 01/31/22 Due: 01/31/23

Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT05084404 Org: User:
Start: 10/29/21 End: 06/30/23 Due: 06/30/24

Elobixibat for Chronic Constipation Without Defecation Desire

Phase: N/A Priority: Normal
NCT ID: NCT05165199 Org: User:
Start: 03/01/22 End: 03/31/23 Due: 03/31/24

Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT06623539 Org: User:
Start: 12/23/20 End: 03/31/26 Due: 03/31/27

Long-term Elobixibat for Chronic Constipation

Phase: N/A Priority: Normal
NCT ID: NCT04784780 Org: User:
Start: 08/06/21 End: 11/30/23 Due: 11/30/24